Innate Pharma to meet its retail investors at Actionaria on November 23 & 24

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces its second participation to Actionaria, a forum dedicated to meeting with individual investors, on November 23 & 24, in Paris.

Innate Pharma representatives will be at booth A20, level 1 on 23 and 24 November. Hervé Brailly will participate in a number of conferences on Friday, November 23:

• 2:25 to 2:40pm : Presidents’ Agora
• 3:05 to 3:20pm: “Midcaps, the economic support of the regions?”
• 3:30 to 4:30pm: Conference-debate : “Midcaps: a socially responsible investment”
• 5:30 to 6:30pm: Conference “Biotech, growth stocks to enhance your portfolio”